IGF2 is a modulator of hippocampal cognition that has been found to be dysregulated in numerous neurodegenerative illnesses, including AD, in recent years (Beletskiy et al., 2021; Pardo et al., 2019). The gene discussed is IGF2; the disease is Alzheimer disease.